½ÃÀ庸°í¼­
»óǰÄÚµå
1471995

µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® : Á¦Ç°º°, Àç·áº°, ±â¼úº°, Áö¿ªº°

Craniomaxillofacial Devices Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Material, Technology, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀåÀº 2023³â 16¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 26¾ï 6,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, 2023-2031³âÀÇ CAGRÀº 5.9%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º´Â ¾ó±¼, µÎ°³°ñ ¹× ÅÎÀ» Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼ö ÀåºñÀÔ´Ï´Ù. ÀÌ Àåºñ´Â À§ÀÇ ºÎÀ§¿Í °ü·ÃµÈ Áúº´, ¼±ÃµÀû Àå¾Ö, ¿Ü»ó °ü·Ã ¼Õ»ó, ±âÇü ¹× ÀÌ»óÀ» Ä¡·áÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ±â±¸µéÀº µÎ°³°ñ°ú ¾ó±¼ÀÇ µ¶Æ¯ÇÑ ÇØºÎÇÐÀû ±¸Á¶¿¡ ¸Â°Ô Á¦ÀÛµÈ ¼ö¼ú ±â±¸, Ç÷¹ÀÌÆ®, ³ª»ç, ÀÓÇöõÆ® µîÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀåÀº ¹Ì¿ë ¼ºÇü ¹× Àç°Ç ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ȣȲÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¹Ì¿ë ¼ºÇü ¼ö¼úÀº ÇØºÎÇÐÀû Ư¡À» ±³Á¤ÇÏ°í º¯°æÇÏ¿© ÀüüÀûÀÎ ¿Ü¸ð¸¦ °³¼±ÇÏ°í ½Ã°¢ÀûÀ¸·Î ´õ ¸Å·ÂÀûÀÎ ¿Ü¸ð¸¦ ¾ò±â À§ÇØ ½ÃÇàµÇ´Â ¹Ý¸é, Àç°Ç ¼ö¼úÀº ¼±ÃµÀû ÀÌ»ó, ¿Ü»ó, ¾ÏÀ» Æ÷ÇÔÇÑ ÀÇÇÐÀû ÁúȯÀ¸·Î ÀÎÇÑ ±âÇüÀ» Ä¡·áÇϱâ À§ÇØ ½ÃÇàµË´Ï´Ù. ¹Ì±¹¿¡ º»»ç¸¦ µÐ ¹Ì¿ë ¼ºÇü ¼ö¼úÀÇ ±ÇÀ§ÀÚÀÎ Aesthetic SocietyÀÇ 2020-2021 ¹Ì¿ë ¼ºÇü ¼ö¼ú Åë°è º¸°í¼­¿¡ µû¸£¸é Áö¹æ ÈíÀÔ, ¾ûµ¢ÀÌ ¼ºÇü, º¹ºÎ ¼ºÇü µî ¹Ì¿ë ¼ºÇü ¼ö¼ú °Ç¼ö´Â 2020³â¿¡ ºñÇØ 2021³â¿¡ 63% Áõ°¡Çß´Ù°í ÇÕ´Ï´Ù. Æò±ÕÀûÀ¸·Î °¢ ¼ºÇü¿Ü°ú ÀÇ»ç´Â 2020³â 220°Ç, 2021³â 320°ÇÀÇ ¼ö¼úÀ» ½ÃÇàÇß½À´Ï´Ù. µû¶ó¼­ Àç°Ç ¼ö¼ú ¹× ¹Ì¿ë ¼ö¼ú °Ç¼ö Áõ°¡´Â µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÇÑÆí, µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º´Â µÎ°³°ñ, ¾ó±¼, ÅÎÀ» Æ÷ÇÔÇÑ º¹ÀâÇÑ ¼ö¼úÀ» À§ÇØ ¼³°èµÈ º¹ÀâÇÏ°í Æ¯¼öÇÑ ±â±¸·Î, ÀÌ·¯ÇÑ Á¦Ç°À» Á¦Á¶ÇÏ·Á¸é °í±Þ Àç·á¿Í ±â¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¿¬±¸°³¹ß, ±ÔÁ¦ Áؼö ¹× Á¤¹Ð ¿£Áö´Ï¾î¸µ ¿ä±¸ »çÇ×Àº µÎ°³¾Ç¾È¸é ±â±â Á¦Á¶ÀÇ ³ôÀº ºñ¿ëÀÇ ¶Ç ´Ù¸¥ ¿øÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. ÀÇ·á ½Ã¼³ÀÇ °æ¿ì, °í°¡ÀÇ µÎ°³¾Ç¾È¸é µð¹ÙÀ̽ºÀÇ Á¶´ÞÀº »ó´çÇÑ ÀçÁ¤Àû ÅõÀÚ¸¦ ÀǹÌÇϸç, ¿¹»ê ¹èºÐ°ú ½ÅÁßÇÑ ÀÚ¿ø °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ µÎ°³¾Ç¾È¸é µð¹ÙÀ̽ºÀÇ °íºñ¿ëÀº ȯÀÚÀÇ Ã·´Ü µÎ°³¾Ç¾È¸éÄ¡·á¿¡ ´ëÇÑ Á¢±Ù¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÀǷẸÇèÀÇ Á¦ÇÑÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ºñ¿ë À庮Àº ÃÖ÷´Ü µÎ°³¾Ç¾È¸é ±â¼úÀÇ Ã¤ÅÃÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î µÎ°³¾Ç¾È¸é µð¹ÙÀ̽ºÀÇ ³ôÀº ºñ¿ëÀº µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. µÎ°³¾Ç¾È¸é µð¹ÙÀ̽ºÀÇ ºñ¿ëÀ» ³·Ãß°í Á¢±Ù¼º°ú Ȱ¿ëµµ¸¦ ±Ø´ëÈ­Çϱâ À§ÇØ ¾÷°è ÀÌÇØ°ü°èÀÚµéÀº ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ °øÁ¤, °¡°Ý Àü·«, »óȯ ¸ðµ¨, °¡Ä¡ ±â¹Ý Ä¡·á Á¢±Ù¹ýÀ» ¸ð»öÇØ¾ß ÇÕ´Ï´Ù.

µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå ºÐ¼®Àº Á¦Ç°, Àç·á, ¿ëµµº° ºÎ¹®À» °í·ÁÇÏ¿© ¼öÇàµË´Ï´Ù. Á¦Ç°º°·Î´Â µÎ°³¾Ç¾È¸é ÆÇ ¹× ³ª»ç °íÁ¤, µÎ°³°ñ Ç÷¦ °íÁ¤, µÎ°³¾Ç¾È¸é µð½ºÆ®·°¼Ç, ÅΰüÀý ġȯ¼ú, ÈäºÎ °íÁ¤, °ñÀÌ½Ä ´ëü µîÀ¸·Î ½ÃÀåÀÌ ±¸ºÐµË´Ï´Ù. Àç·áº°·Î´Â ±Ý¼Ó, »ýüÈí¼ö¼º Àç·á, ¼¼¶ó¹ÍÀ¸·Î ±¸ºÐµË´Ï´Ù. ¿ëµµº°·Î´Â ½Å°æ¿Ü°ú, À̺ñÀÎÈİú, ±¸°­¾Ç¾È¸é¿Ü°ú, ¼ºÇü¿Ü°ú·Î ¼¼ºÐÈ­µË´Ï´Ù.

µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå Á¶»ç ¹üÀ§´Â ºÏ¹Ì(¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ), À¯·´(¿µ±¹, µ¶ÀÏ, ÇÁ¶û½º, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ, Àεµ, È£ÁÖ, Çѱ¹, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç), Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(¾Æ¶ø¿¡¹Ì¸®Æ®, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾ÆÇÁ¸®Ä«, ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«), Áß³²¹Ì(ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì)¸¦ Æ÷ÇÔÇÑ´Ù, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾ÆÇÁ¸®Ä«, ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«), Áß³²¹Ì(ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ Áß³²¹Ì)°¡ Æ÷ÇԵǸç, 2023³â¿¡´Â ºÏ¹Ì°¡ µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ½ºÆ÷Ã÷ °ü·Ã ±â¾÷ÀÇ ±Þ°ÝÇÑ Áõ°¡, ¾È¸é °ñÀý ȯÀÚ Áõ°¡, ±¹Á¦ÀûÀÎ ¿îµ¿¼±¼öµéÀÇ Á¸Àç µîÀÌ ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì·Î ºÐ·ùµË´Ï´Ù.

µÎ°³¾Ç¾È¸é(CMF) ±â±â ½ÃÀå Á¶»ç ¹üÀ§´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì¸¦ Æ÷°ýÇÕ´Ï´Ù. ºÏ¹Ì´Â 2023³â µÎ°³¾Ç¾È¸é(CMF) ±â±â ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ Áß ±× ¿ìÀ§(Á¡À¯À² ±âÁØ)¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹Àº ºÏ¹Ì¿Í ¼¼°è¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ¹× ¾È¸é °ñÀý Áõ°¡¿Í ±¹Á¦ ½ºÆ÷Ã÷ ¼±¼öµéÀÇ ¹Ì±¹ ÁøÃâÀÌ ¹Ì±¹ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, µÎ°³¾Ç¾È¸é °íÁ¤¼úÀÇ ±â¼ú ¹ßÀüÀÌ ÀÌ Áö¿ªÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå ±¸µµ

  • PEST ºÐ¼®
  • ¿¡ÄڽýºÅÛ ºÐ¼®
    • ¹ë·ùüÀÎÀÇ º¥´õ ¸®½ºÆ®

Á¦5Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ
  • ÁÖ¿ä ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ÁÖ¿ä ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ
  • ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®

Á¦6Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

  • µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå - ¼¼°è ½ÃÀå °³¿ä
  • µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º - ¼¼°è ½ÃÀå ¹× ¿¹Ãø(-2031³â)

Á¦7Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå - ¸ÅÃ⠺м® - Á¦Ç°º°, 2021-2031³â

  • µÎ°³ Ç÷¦ °íÁ¤
  • CMF µð½ºÆ®·¢¼Ç
  • ¾Ç°üÀý ġȯ¼ú
  • ÈäÃß °íÁ¤
  • °ñÀ̽Ä
  • CMF Ç÷¹ÀÌÆ® ¹× ½ºÅ©·ù °íÁ¤

Á¦8Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå - ¸ÅÃ⠺м® - Àç·áº°, 2021-2031³â

  • ±Ý¼Ó
  • »ýüÈí¼ö¼º Àç·á
  • ¼¼¶ó¹Í

Á¦9Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå - ¸ÅÃ⠺м® - ¿ëµµº°, 2021-2031³â

  • ½Å°æ¿Ü°ú ¹× À̺ñÀÎÈİú
  • Åα³Á¤ ¹× Ä¡°ú ¿Ü°ú
  • ¼ºÇü¿Ü°ú

Á¦10Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå - ¸ÅÃ⠺м® - Áö¿ª ºÐ¼®,2021-2031³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ¿µ±¹
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • È£ÁÖ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦11Àå ¾÷°è »óȲ

  • ÇÕº´°ú Àμö
  • °è¾à, Á¦ÈÞ, ÇÕº´»ç¾÷
  • ½ÅÁ¦Ç° Ãâ½Ã
  • »ç¾÷ È®´ë¿Í ±âŸ Àü·«Àû °³¹ß

Á¦12Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷¿¡ ÀÇÇÑ È÷Æ®¸Ê ºÐ¼®
  • ±â¾÷ÀÇ Æ÷Áö¼Å´×°ú ÁýÁßµµ

Á¦13Àå µÎ°³¾Ç¾È¸é µð¹ÙÀ̽º ½ÃÀå - ÁÖ¿ä ±â¾÷ °³¿ä

  • DePuy Synthes
  • Stryker
  • Medtronic
  • B. Braun Melsungen AG
  • Reni Shaw plc.
  • Medartis AG
  • KLS Martin Group
  • Xilloc Medical B. V
  • Synimed
  • Zimmer-Biomet

Á¦14Àå ºÎ·Ï

KSA 24.05.23

The craniomaxillofacial devices market is expected to grow from US$ 1.68 billion in 2023 to US$ 2.66 billion by 2031; the market is anticipated to record a CAGR of 5.9% from 2023 to 2031.

Craniomaxillofacial devices are specialized equipment used for facial, skull, and jaw treatments. These devices are vital for the treatment of illnesses, congenital disabilities, trauma-related injuries, deformities, and anomalies associated with the abovementioned areas. They consist of surgical instruments, plates, screws, and implants made to fit the unique cranial and face anatomical structures.

The craniomaxillofacial devices market is flourishing with the rising demand for cosmetic and reconstructive procedures. While cosmetic procedures are carried out to improve overall appearance by reshaping and altering anatomical characteristics to gain a visually more appealing look, reconstructive surgeries are carried out to address deformities induced by birth abnormalities, trauma, or medical diseases, including cancer. The 2020-2021 Aesthetic Plastic Surgery Statistics report of Aesthetic Society, a US-based authority on aesthetic plastic surgeries, states that the number of aesthetic operations such as liposuction, buttock augmentation, and abdominoplasty grew by 63% in 2021 compared to 2020. On average, each plastic surgeon executed 320 surgical procedures in 2021 compared to 220 in 2020. Therefore, the rising number of reconstructive and cosmetic procedures contributes to the expansion of the craniomaxillofacial devices market.

On the other hand, the high cost associated with craniomaxillofacial devices limits the market growth. Craniomaxillofacial devices are intricate and specialized instruments designed for complex surgeries involving the skull, face, and jaws; the manufacturing of these products requires advanced materials and technologies. Research and development, regulatory compliance, and precision engineering requirements further contribute to the high cost of craniomaxillofacial device manufacturing. For healthcare facilities, procuring expensive craniomaxillofacial devices represents a significant financial investment, often requiring budget allocations and careful resource management. Additionally, the high cost of craniomaxillofacial devices can affect patients' access to advanced craniomaxillofacial treatments and potentially lead to limitations in healthcare coverage. The cost barrier may restrict the adoption of cutting-edge craniomaxillofacial technologies. As a result, the high cost of craniomaxillofacial devices limits the market growth of craniomaxillofacial devices. To lower the cost of craniomaxillofacial devices to maximize their affordability and accessibility, industry stakeholders need to explore cost-effective manufacturing processes, pricing strategies, reimbursement models, and value-based care approaches.

The craniomaxillofacial devices market analysis has been carried out by considering the following segments: product, material, and application. By product, the market is divided into craniomaxillofacial plate and screw fixation, cranial flap fixation, Craniomaxillofacial distraction, temporomandibular joint replacement, thoracic fixation, and bone graft substitute. Based on material, the market is segmented into metals, bioabsorbable materials, and ceramics. In terms of application, the market is fragmented into neurosurgery and ENT, orthognathic and dental surgery, and plastic surgery.

The scope of the craniomaxillofacial devices market report includes North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). In 2023, North America held the largest craniomaxillofacial devices market share. A surge in participation in sports, an increase in the number of facial fracture cases, and the presence of a large number of international athletes contribute to the market growth in the US.

Based on geography, the craniomaxillofacial devices market is classified into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.

The scope of the Craniomaxillofacial (CMF) Devices Market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest share of the Craniomaxillofacial (CMF) Devices Market in 2023, and it is projected to maintain its dominance (in terms of share) during the forecast period. The US holds the largest market share in North America and the world. The rise in sports and facial fractures and the national presence of all international athletes are driving the market growth in the US. The demand for minimally invasive operations is rising, and advances in technology in craniomaxillofacial fixation contribute to this rise in the investigated region.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Craniomaxillofacial Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Craniomaxillofacial Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Craniomaxillofacial Devices Market - Global Market Analysis

  • 6.1 Craniomaxillofacial Devices - Global Market Overview
  • 6.2 Craniomaxillofacial Devices - Global Market and Forecast to 2031

7. Craniomaxillofacial Devices Market - Revenue Analysis (USD Million) - By Product, 2021-2031

  • 7.1 Overview
  • 7.2 Cranial Flap Fixation
  • 7.3 CMF Distraction
  • 7.4 Temporomandibular Joint Replacement
  • 7.5 Thoracic Fixation
  • 7.6 Bone Graft Substitute
  • 7.7 CMF Plate and Screw Fixation

8. Craniomaxillofacial Devices Market - Revenue Analysis (USD Million) - By Material, 2021-2031

  • 8.1 Overview
  • 8.2 Metal
  • 8.3 Bio absorbable material
  • 8.4 Ceramics

9. Craniomaxillofacial Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 9.1 Overview
  • 9.2 Neurosurgery and ENT
  • 9.3 Orthognathic and Dental Surgery
  • 9.4 Plastic surgery

10. Craniomaxillofacial Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Craniomaxillofacial Devices Market Overview
    • 10.1.2 North America Craniomaxillofacial Devices Market Revenue and Forecasts to 2031
    • 10.1.3 North America Craniomaxillofacial Devices Market Revenue and Forecasts and Analysis - By Product
    • 10.1.4 North America Craniomaxillofacial Devices Market Revenue and Forecasts and Analysis - By Material
    • 10.1.5 North America Craniomaxillofacial Devices Market Revenue and Forecasts and Analysis - By Application
    • 10.1.6 North America Craniomaxillofacial Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Craniomaxillofacial Devices Market
        • 10.1.6.1.1 United States Craniomaxillofacial Devices Market, by Product
        • 10.1.6.1.2 United States Craniomaxillofacial Devices Market, by Material
        • 10.1.6.1.3 United States Craniomaxillofacial Devices Market, by Application
      • 10.1.6.2 Canada Craniomaxillofacial Devices Market
        • 10.1.6.2.1 Canada Craniomaxillofacial Devices Market, by Product
        • 10.1.6.2.2 Canada Craniomaxillofacial Devices Market, by Material
        • 10.1.6.2.3 Canada Craniomaxillofacial Devices Market, by Application
      • 10.1.6.3 Mexico Craniomaxillofacial Devices Market
        • 10.1.6.3.1 Mexico Craniomaxillofacial Devices Market, by Product
        • 10.1.6.3.2 Mexico Craniomaxillofacial Devices Market, by Material
        • 10.1.6.3.3 Mexico Craniomaxillofacial Devices Market, by Application

Note - Similar analysis would be provided for below mentioned regions/countries

  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Craniomaxillofacial Devices Market - Key Company Profiles

  • 13.1 DePuy Synthes
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 13.2 Stryker
  • 13.3 Medtronic
  • 13.4 B. Braun Melsungen AG
  • 13.5 Reni Shaw plc.
  • 13.6 Medartis AG
  • 13.7 KLS Martin Group
  • 13.8 Xilloc Medical B. V
  • 13.9 Synimed
  • 13.10 Zimmer-Biomet

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦